down arrow

Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
29.53
-0.6 (-1.99%)
BSENSE

Apr 11, 12:37 PM

BSE+NSE Vol: 16000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

16.0 k (11.11%) Volume

Shareholding (Sep 2024)

FII

13.07%

Held by 5 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

57.39%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 725 Cr (Micro Cap)

stock-summary
P/E

64.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.94

stock-summary
Return on Equity

10.18%

stock-summary
Price to Book

6.50

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-27.09%
0%
-27.09%
1 Year
289.06%
0%
289.06%
2 Years
324.4%
0%
324.4%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.3 per share ex-dividend date: Aug-25-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
33.20%
EBIT Growth (5y)
48.28%
EBIT to Interest (avg)
2.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0
Tax Ratio
24.77%
Dividend Payout Ratio
10.26%
Pledged Shares
0
Institutional Holding
13.07%
ROCE (avg)
0
ROE (avg)
11.66%
Valuation key factors
Factor
Value
P/E Ratio
64
Industry P/E
33
Price to Book Value
6.50
EV to EBIT
38.86
EV to EBITDA
36.74
EV to Capital Employed
3.83
EV to Sales
1.78
PEG Ratio
1.04
Dividend Yield
NA
ROCE (Latest)
9.85%
ROE (Latest)
10.18%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (13.07%)

Promoter with highest holding

Sachin Vasantrai Mehta (27.51%)

Highest Public shareholder

Ag Dynamic Funds Limited (3.99%)

Individual Investors Holdings

23.2%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sudarshan Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -1.70% vs -0.03% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -10.30% vs 35.52% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "227.79",
          "val2": "231.74",
          "chgp": "-1.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.57",
          "val2": "14.42",
          "chgp": "14.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.51",
          "val2": "5.73",
          "chgp": "31.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.92",
          "val2": "6.60",
          "chgp": "-10.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.27%",
          "val2": "6.22%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sudarshan Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.48% vs 29.19% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 62.78% vs 34.10% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "463.54",
          "val2": "461.33",
          "chgp": "0.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.81",
          "val2": "14.69",
          "chgp": "55.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.94",
          "val2": "5.40",
          "chgp": "65.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.46",
          "val2": "7.04",
          "chgp": "62.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.92%",
          "val2": "3.18%",
          "chgp": "1.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Mar'24
Change(%)
Net Sales
227.79
231.74
-1.70%
Operating Profit (PBDIT) excl Other Income
16.57
14.42
14.91%
Interest
7.51
5.73
31.06%
Exceptional Items
-1.17
0.00
Consolidate Net Profit
5.92
6.60
-10.30%
Operating Profit Margin (Excl OI)
7.27%
6.22%
1.05%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -1.70% vs -0.03% in Mar 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -10.30% vs 35.52% in Mar 2024

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
463.54
461.33
0.48%
Operating Profit (PBDIT) excl Other Income
22.81
14.69
55.28%
Interest
8.94
5.40
65.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.46
7.04
62.78%
Operating Profit Margin (Excl OI)
4.92%
3.18%
1.74%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 0.48% vs 29.19% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 62.78% vs 34.10% in Mar 2023

stock-summaryCompany CV
About Sudarshan Pharma Industries Ltd stock-summary
stock-summary
Sudarshan Pharma Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Sudarshan Pharma Industries Limited was originally incorporated as a Private Limited Company with the name "Sudarshan Specialty Chemsolve Private Limited" on July 23, 2008 with the Registrar of Companies, Mumbai. Later in the year 2016. name of the Company was changed from "Sudarshan Specialty Chemsolve Private Limited" to "Sudarshan Pharma Industries Private Limited" on 17 December 2016.
Company Coordinates stock-summary
Icon
No Company Details Available